Brief: Ipsen’s Iqirvo Receives European Approval

Ipsen SA

20/09/2024 14:02

Sept 20 (Reuters) - Ipsen SA  IPN.PA :
    * IPSEN’S IQIRVO® (ELAFIBRANOR) APPROVED IN THE EUROPEAN
UNION AS
FIRST NEW TREATMENT FOR PRIMARY BILIARY CHOLANGITIS IN NEARLY A
DECADE
    * APPROVAL FOLLOWS POSITIVE CHMP OPINION BASED ON ELATIVE
PHASE
III TRIAL DATA

Source text for Workspace:  ID:nGNX9KlXHf 
Further company coverage:  IPN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48587696600;))